Exploring Wellbeing Outcomes in Adolescents Using Bifidobacterium Longum, 1714™: a Prospective Open-Label Real-World Study

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age15-17
SponsorNovonesis

About this trial

The purpose of this study is to evaluate changes in self-reported wellbeing outcomes in adolescents. Bifidobacterium longum, 1714™ has previously been associated with beneficial effects on stress-related outcomes, sleep quality, subjective wellbeing and aspects of cognitive performance, however evidence in adolescents is limited. This study will evaluate changes in outcomes related to anxiety, sleep, fatigue, cognitive function and other wellbeing outcomes following daily consumption of Bifidobacterium longum, 1714™ under real-world conditions.

Eligibility criteria

Qualifiers

Aged 15-17 years at the time of study screening

Able and willing to provide informed consent or assent, with parental consent where applicable.

Enrolled in school or college at the time of screening

Participants must be able to read and understand English.

Disqualifiers

Pregnant, breastfeeding, or planning pregnancy during the study period

Known allergy or intolerance to any component of the study product

Pose a safety risk, or

Confound interpretation of study outcomes, as judged by the Investigator

Trial design

Treatments tested in this trial

  • Bifidobacterium longum, 1714™

Treatment groups

150 Participants
are divided into 1 treatment group

Sponsors and collaborators